648917-75-3 Usage
Explanation
The molecular formula represents the number of atoms of each element present in a molecule. In this case, the compound has 9 carbon (C), 8 hydrogen (H), 1 chlorine (Cl), 5 nitrogen (N), and 1 oxygen (O) atoms.
Explanation
The compound's structure consists of a triazine ring (a six-membered ring with three nitrogen atoms) and a phenyl group (a six-membered ring with alternating single and double carbon-carbon bonds) that has a methyl group (-CH3) and an amino group (-NH2) as substituents.
Explanation
Due to its unique structure and properties, 1,2,4-Triazin-5(2H)-one, 3-(3-amino-4-chlorophenyl)-6-methyl- serves as a valuable building block for creating new pharmaceutical agents and chemical compounds with potential therapeutic applications.
Explanation
The compound is also used in research and development processes to explore its possible biological activities and pharmacological properties, which could lead to the discovery of new drugs or therapies.
Explanation
The solubility of the compound in different solvents is not mentioned in the given information. Solubility is an important property for determining how a compound interacts with other substances and its potential applications.
Explanation
The stability of the compound under various conditions (e.g., temperature, pH, etc.) is not provided. Stability is crucial for understanding how the compound behaves and its suitability for specific applications.
Explanation
The reactivity of the compound with other chemicals or under different conditions is not mentioned. Reactivity is essential for determining how the compound can be synthesized, modified, or used in various applications.
Explanation
The toxicity of the compound, which refers to its potential harmful effects on living organisms, is not provided. Understanding toxicity is vital for assessing the compound's safety and potential applications in the pharmaceutical industry.
Chemical Structure
Heterocyclic compound with a triazine ring and a methyl and amino-substituted phenyl group
Pharmaceutical Applications
Used in the synthesis of various drugs and biologically active molecules
Research and Development
Utilized for its potential biological activities and pharmacological properties
Solubility
Not specified in the provided material
Stability
Not specified in the provided material
Reactivity
Not specified in the provided material
Toxicity
Not specified in the provided material
Check Digit Verification of cas no
The CAS Registry Mumber 648917-75-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,4,8,9,1 and 7 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 648917-75:
(8*6)+(7*4)+(6*8)+(5*9)+(4*1)+(3*7)+(2*7)+(1*5)=213
213 % 10 = 3
So 648917-75-3 is a valid CAS Registry Number.
648917-75-3Relevant academic research and scientific papers
HETEROCYCLICALLY SUBSTITUTED BENZOYLUREAS, METHOD FOR THEIR PRODUCTION AND THEIR USE AS MEDICAMENTS
-
Page/Page column 34, (2008/06/13)
The invention relates to heterocyclically substituted benzoylureas, in addition to their physiologically compatible salts and physiologically functional derivatives. The invention relates in particular to compounds of formula (I), in which the groups are defined as cited in the description, in addition to their physiologically compatible salts and to a method for producing said compounds. The compounds are suitable e.g. for treating type 2 diabetes.
